B. Riley's just raised its QBTS price target to $22 a share, with a buy rating.

Stock price-driven narratives often overshadow company fundamentals, leading to significant mispricings, as seen with D.R. Horton and Alexandria Real Estate Equities. DHI's selloff was fueled by negative sentiment around mortgage rates and housing, ignoring its strong balance sheet, high margins, and operational flexibility. DHI's recent earnings shattered the negative narrative, proving its resilience and leaving the stock undervalued at just over 12X trough earnings.

RCKT INVESTOR ALERT: Rocket Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit — Neutral
RCKT PRNewsWire — July 23, 2025SAN DIEGO , July 23, 2025 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that the Rocket Pharmaceuticals class action lawsuit – captioned Ho v. Rocket Pharmaceuticals, Inc., No.

Live Coverage: Will Las Vegas Sand (LVS) Stock Soar After Earnings? — Positive
LVS 24/7 Wall Street — July 23, 2025All eyes on Macau: June GGR strength raises the bar for Q2 recovery pace and VIP volume.

Oatly Group AB (NASDAQ:OTLY ) Q2 2025 Earnings Conference Call July 23, 2025 8:00 AM ET Company Participants Brian Kearney - Vice President of Investor Relations Daniel Ordonez - Global President & COO Jean-Christophe Flatin - Chief Executive Officer Marie-Jose David - Chief Financial Officer Conference Call Participants John Joseph Baumgartner - Mizuho Securities USA LLC, Research Division Kaumil S. Gajrawala - Jefferies LLC, Research Division Operator Good day, and welcome to the Oatly Second Quarter 2025 Earnings Conference Call.

Janus Henderson Lists New Asset-Backed Securities ETF — Positive
JAAA JMBS ETF Trends — July 23, 2025On Wednesday, Janus Henderson expanded its ETF lineup with the launch of the Janus Henderson Asset-Backed Securities ETF (JABS). JABS is an actively managed fund that looks to generate a mix of income and capital preservation.

SSRM vs. AU: Which Gold Mining Stock Shines Brighter in 2025? — Positive
AU SSRM Zacks Investment Research — July 23, 2025AngloGold Ashanti edges ahead of SSR Mining with higher output, a leaner cost structure and a new dividend policy appealing to income seekers.

CME Q2 Earnings, Revenues Beat Estimates on Higher Trading Volume — Positive
CME Zacks Investment Research — July 23, 2025CME posts Q2 beats on earnings and revenue as record trading volume and rising fees lift results amid market volatility.

BigBear.ai vs. Veritone: Which AI Analytics Stock is the Smarter Play? — Positive
BBAI VERI Zacks Investment Research — July 23, 2025Artificial intelligence analytics is a burgeoning niche, and BigBear.ai BBAI and Veritone VERI have emerged as two notable small-cap players in this space. Both companies offer AI-driven software and solutions that help organizations derive actionable intelligence from data.

4 Technology Stocks Poised to Beat Earnings Estimates in Q2 — Positive
FLEX LRCX META STX Zacks Investment Research — July 23, 2025Here, we have picked four technology stocks, META, LRCX, FLEX and STX, which are likely to pull off earnings surprises in second-quarter 2025.

Will Arista Networks (ANET) Beat Estimates Again in Its Next Earnings Report? — Positive
ANET Zacks Investment Research — July 23, 2025Arista Networks (ANET) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Will Crocs (CROX) Beat Estimates Again in Its Next Earnings Report? — Positive
CROX Zacks Investment Research — July 23, 2025Crocs (CROX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Will Ralph Lauren (RL) Beat Estimates Again in Its Next Earnings Report? — Positive
RL Zacks Investment Research — July 23, 2025Ralph Lauren (RL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Can California Water Service Group (CWT) Keep the Earnings Surprise Streak Alive? — Positive
CWT Zacks Investment Research — July 23, 2025California Water Service Group (CWT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Why Esab (ESAB) is Poised to Beat Earnings Estimates Again — Positive
ESAB Zacks Investment Research — July 23, 2025Esab (ESAB) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Can Sprouts Farmers (SFM) Keep the Earnings Surprise Streak Alive? — Positive
SFM Zacks Investment Research — July 23, 2025Sprouts Farmers (SFM) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Will Magnolia Oil & Gas Corp (MGY) Beat Estimates Again in Its Next Earnings Report? — Positive
MGY Zacks Investment Research — July 23, 2025Magnolia Oil & Gas Corp (MGY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Why MKS (MKSI) is Poised to Beat Earnings Estimates Again — Positive
MKSI Zacks Investment Research — July 23, 2025MKS (MKSI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Why MarketAxess (MKTX) Could Beat Earnings Estimates Again — Positive
MKTX Zacks Investment Research — July 23, 2025MarketAxess (MKTX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Will Merit Medical (MMSI) Beat Estimates Again in Its Next Earnings Report? — Positive
MMSI Zacks Investment Research — July 23, 2025Merit Medical (MMSI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
